We are live on ! Find out more
GA

Gagnon Advisors Portfolio holdings

AUM $136M
1-Year Est. Return 21.55%
This Fund
S&P 500
This Quarter Est. Return
-5.11%
1 Year Est. Return
+21.55%
3 Year Est. Return
+78.18%
5 Year Est. Return
+93.01%
10 Year Est. Return
+1,298.31%
AUM
$252M
AUM Growth
-$11M
Cap. Flow
+$8.03M
Cap. Flow %
3.18%
Top 10 Hldgs %
51.05%
Holding
39
New
7
Increased
8
Reduced
4
Closed
4

Top Buys

Rank Stock Value
1
EVA
Enviva Inc.
EVA
+$7.78M
2
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
+$5.78M
3
ZUO
Zuora, Inc.
ZUO
+$5.69M
4
FRSH icon
Freshworks
FRSH
+$5.31M
5
WGS icon
GeneDx Holdings
WGS
+$3.86M

Top Sells

Rank Stock Value
1
AMRC icon
Ameresco
AMRC
+$6.64M
2
CMLFU
CM Life Sciences, Inc. Unit
CMLFU
+$5.84M
3
ONTO icon
Onto Innovation
ONTO
+$5.65M
4
DVN icon
Devon Energy
DVN
+$5.22M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$4.93M

Sector Composition

Rank Sector Weight
1 Technology 40.57%
2 Healthcare 27.44%
3 Industrials 13.66%
4 Energy 5.81%
5 Consumer Discretionary 3.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNF
26
CNFinance Holdings
CNF
$37.1M
$3.94M 1.56%
66,757
– –
CELC icon
27
Celcuity
CELC
$4.27B
$3.38M 1.34%
187,873
– –
WGS icon
28
GeneDx Holdings
WGS
$2.05B
$2.81M 1.12%
+11,225
New +$3.86M
PSIX
29
Power Solutions International
PSIX
$641M
$2.51M 0.99%
626,584
– –
MIRO
30
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
$1.6M 0.63%
229,802
– –
ETWO.WS
31
DELISTED
E2open Parent Holdings, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
ETWO.WS
$813K 0.32%
280,316
+44,424
+19% +$133K
SLGCW
32
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$354K 0.14%
+102,594
New +$316K
WGSWW
33
DELISTED
GeneDx Holdings Warrant
WGSWW
$262K 0.1%
+123,469
New +$406K
TFFP
34
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$143K 0.06%
743
-6,316
-89% -$1.34M
DVN icon
35
Devon Energy
DVN
$50.9B
– –
-178,783
Closed -$5.22M
CMLTU
36
DELISTED
CM Life Sciences III Inc. Unit
CMLTU
– –
-259,710
Closed -$2.84M
CMIIU
37
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
– –
-366,905
Closed -$4.93M
CMLFU
38
DELISTED
CM Life Sciences, Inc. Unit
CMLFU
– –
-370,410
Closed -$5.84M
1
2

Similar funds

WF
Womack Financial Dallas, Texas $136M AUM 19.05% 1-Year Est. Return
MWA
Muirfield Wealth Advisors Charlotte, North Carolina $136M AUM 14.77% 1-Year Est. Return
SSCM
Sovereign's Capital Management Atlanta, Georgia $136M AUM 5.11% 1-Year Est. Return
BDCMI
Black Diamond Capital Management I St. Thomas $136M AUM
WA
WPG Advisers Baltimore, Maryland $136M AUM 24.41% 1-Year Est. Return
LCM
LuminArx Capital Management New York $136M AUM
NVCHI
New Vernon Capital Holdings II Morristown, New Jersey $136M AUM 29.35% 1-Year Est. Return
GPWA
Gaddis Premier Wealth Advisors Durant, Oklahoma $136M AUM

Gagnon Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Gagnon Advisors held 39 positions worth $252M, down 4.2% from $263M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Gagnon Advisors deployed $8.03M of net new capital in Q3 2021, opening 7 new positions and adding to 8 existing holdings. Its largest new stake was Enviva Inc.: 144,777 shares worth $7.83M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Ameresco, an estimated $6.64M trimmed.

  • Gagnon Advisors's largest Q3 2021 buy was Enviva Inc.: 144,777 shares worth $7.83M.
  • Gagnon Advisors added most to E2open Parent Holdings in Q3 2021, an estimated $2.77M increase.
  • Gagnon Advisors's biggest Q3 2021 reduction was Ameresco, cutting an estimated $6.64M.
  • Gagnon Advisors fully exited CM Life Sciences, Inc. Unit in Q3 2021, selling an estimated $5.84M.
  • Gagnon Advisors's ten largest holdings make up 51% of its $252M portfolio in Q3 2021.
  • Gagnon Advisors opened 7 new positions and closed 4 in Q3 2021.
  • Gagnon Advisors's portfolio value fell 4.2% quarter-over-quarter to $252M.

Based on Gagnon Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.